Saba Capital Management, L.P. bought HQL
April 22, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 2,022 shares of Abrdn Life Sciences Investors at $12.88 per share, a transaction worth $26.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
2,022
Price
$12.88
Total value
$26.0K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateApril 22, 2024
Filing dateApril 23, 2024
Shares owned after2,738,992
OwnershipIndirect
10b5-1 planNo
AmendedNo